Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SABMilller Chairman sells over 11m pounds in shares

Tue, 23rd Jul 2013 16:21

Graham Mackay, the Chairman of SABMiller who is currently on a medical leave of absence due to a brain tumour, has sold over 11m pounds-worth of shares in the company.Mackay sold a total of 350,000 shares between July 16-18th through three separate transactions, the firm revealed on Tuesday. He sold: 138,000 at 3,266.8p each; 50,000 at 3,250.74p each; and another 162,000 at 3,251.4p each.He pocketed £11.4m through the sale, leaving his holding at just over 1.4m shares.The director first joined the beverages company back in 1978 when it was known as South African Breweries and was its Chief Executive Officer (CEO) at the time of its listing in London in 1999. The company was renamed to SABMiller following the purchase of US group Miller Brewing Company in 2002.Mackay was appointed Executive Chairman in July 2012 but, after being diagnosed with a brain tumour in April, the firm accelerated the promotion of Alan Clark to CEO with Mackay taking a more back-seat position of Non-Executive Chairman. At the time of Clark's appointment, the company said it would keep Mackay's position under review until the outcome of his treatment following surgery in April.SABMiller's share price has increased by nearly 16% since the start of 2013.Top Director BuysVerona Pharma (VRP) Director name: Mr Stuart BottomlyAmount purchased: 3,000,000 @ 1.67p Value: £50,100Scancell Holdings (SCLP) Director name: Ms Katherine Cornish-BowdenAmount purchased: 45,000 @ 32.00p Value: £14,400Top Director SellsSABMiller (SAB) Director name: Mr Graham MackayAmount sold: 162,000 @ 3,251.40p Value: £5,267,268SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 138,000 @ 3,266.80p Value: £4,508,184SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 50,000 @ 3,250.74p Value: £1,625,370Accsys Technologies (AXS) Director name: Mr Paul Hugh Anthony Clegg Amount sold: 1,500,000 @ € 0.14 Value: € 204,000Accsys Technologies (AXS) Director name: Mr Hans Pauli Amount sold: 330,000 @ € 0.14 Value: € 44,880Accsys Technologies (AXS) Director name: Mr William Bickerton RudgeAmount sold: 119,686 @ € 0.14 Value: € 16,277BC
More News
12 Jan 2015 11:55

Verona Pharma doses first volunteers in 'RPL554' asthma trial

Verona Pharma said the first group of volunteers have been dosed with its new nebulised formulation of its RPL554 product as part of a Phase I/II clinical trial, which analysts said was a significant step. The AIM company said the study's main objective was to confirm the safety, tolerability and br

Read more
12 Jan 2015 09:23

Verona Pharma Doses First Recruitments In RPL554 Clinical Trial

Read more
30 Sep 2014 12:38

CORRECT: UK WINNERS & LOSERS: Intertek's Gain Is Inchcape's Loss On CEO Change

Read more
30 Sep 2014 12:35

UK MIDDAY BRIEFING: Clothing Retailers Hit By Next Weather Warning

Read more
30 Sep 2014 11:51

UK WINNERS & LOSERS: Intertek's Gain Is Inchcape's Loss On CEO Change

Read more
30 Sep 2014 09:07

Verona Pharma Appoints Biresh Roy As Chief Financial Officer

Read more
29 Sep 2014 07:45

Verona Shares Up As Data Shows Potential Of RPL554 In Cystic Fibrosis

Read more
11 Sep 2014 11:01

Verona Pharma Posts Widened Loss As It Continues Drug Development

Read more
23 Jun 2014 10:47

UK MIDDAY BRIEFING: ASOS Hit By Suspicious Warehouse Fire

Read more
23 Jun 2014 10:10

UK WINNERS & LOSERS: Mining Companies Cheered By China PMI Data

Read more
23 Jun 2014 07:27

UK MORNING BRIEFING: Shares Down As Iraq Fighting Lifts Oil Prices

Read more
23 Jun 2014 06:47

Verona Pharma To Halt VRP700 Development After Trial Failure

Read more
28 Apr 2014 08:53

Verona Pharma Loss Widens As It Continues To Develop Pipeline Drugs

LONDON (Alliance News) - Verona Pharma PLC Monday posted a widened pretax loss for 2013 as it continued to develop its two pipeline drugs towards commercialisation. Veron posted a pretax loss of GBP2.8 million, widened from a pretax loss of GBP2.6 million in 2012, as administration expense

Read more
7 Mar 2014 12:51

UK MIDDAY BRIEFING: Boohoo.com Latest On IPO Catwalk

LONDON (Alliance News) - Online fashion retailer Boohoo.com, the latest UK retailer to firm up its initial public offering, has said it plans to raise GBP300 million in the AIM listing, giving it a higher-then-expected initial market capitalisation of GBP560 million.

Read more

7 Mar 2014 10:57

UK WINNERS & LOSERS: Aviva Leads Blue-Chip Risers Again

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Aviva, up 4.2%. After closing as the blue-chip index's biggest riser on Thursday, Aviva is again the stand out performer Frid

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.